Lifestyle Modification Program for Reversing Heart Disease Effective Date November 26, 2014

Size: px
Start display at page:

Download "Lifestyle Modification Program for Reversing Heart Disease Effective Date November 26, 2014"

Transcription

1 Medical Plicy BSC8.01 Sectin 8.0 Therapy Subsectin Lifestyle Mdificatin Prgram fr Reversing Heart Disease Effective Date Nvember 26, 2014 Original Plicy Date Nvember 26, 2014 Next Review Date Nvember 2015 Descriptin The Dr. Dean Ornish Prgram fr Reversing Heart Disease is a multifaceted prgram addressing the well-being f bth the bdy and the mind. By cncentrating n fur main cmpnents (healthy eating, mderate exercise, stress management, and emtinal supprt) including smking preventin/cessatin, it is prpsed that heart disease can be prevented, slwed, and even reversed. The prgram is cnsidered t be an Intensive cardiac rehabilitatin (ICR) prgram and prpsed as a nn-surgical alternative fr the treatment f crnary artery disease. Related Plicies Cardiac Rehabilitatin in the Outpatient Setting Plicy Intensive cardiac rehabilitatin (ICR, i.e., Dr. Dean Ornish Prgram fr Reversing Heart Disease) may be cnsidered medically necessary in patients when bth f the fllwing are met: Nn-smker r have quit smking at least 3 mnths prir t enrlling in prgram Have experienced ne r mre f the fllwing cnditins: Acute mycardial infarctin (MI) within the preceding 12 mnths Crnary artery bypass surgery Current stable angina pectris Heart r heart-lung transplant Heart valve repair r replacement Percutaneushj transluminal crnary angiplasty r crnary stenting Plicy Guidelines The prgram is limited t nce per lifetime and prspective participants shuld be mtivated t cmplete the prgram and make the necessary lifestyle changes. Due t the cmprehensive lifestyle changes required, insufficiently mtivated individuals are nt recmmended as candidates fr the Ornish prgram. Individuals must g thrugh a preliminary screening prcess prir t acceptance int the prgram, which is ffered by the licensed Ornish prvider and ensures that the individual is sufficiently mtivated and 1

2 Medical Plicy meets the eligible criteria. Acceptance int the prgram fr a particular individual is at the sle discretin f the applicable Ornish prvider. Intensive cardiac rehabilitatin (ICR) prgrams are limited t 72 ne-hur sessins, up t 6 sessins per day, ver a perid f up t 18 weeks.(1) As f 2014, the nly certified facility in Califrnia ffering this prgram is the University f Califrnia, Ls Angeles (UCLA) Health System Westwd Campus. Cding: G0422: Intensive cardiac rehabilitatin; with r withut cntinuus ECG mnitring with exercise, per sessin G0423: Intensive cardiac rehabilitatin; with r withut cntinuus ECG mnitring; withut exercise, per sessin Benefit Applicatin Benefit determinatins shuld be based in all cases n the applicable cntract language. T the extent there are any cnflicts between these guidelines and the cntract language, the cntract language will cntrl. Please refer t the member's cntract benefits in effect at the time f service t determine cverage r nncverage f these services as it applies t an individual member. Sme state r federal mandates (e.g., Federal Emplyee Prgram (FEP)) prhibit Plans frm denying Fd and Drug Administratin (FDA) - apprved technlgies as investigatinal. In these instances, plans may have t cnsider the cverage eligibility f FDA-apprved technlgies n the basis f medical necessity alne. Ratinale Backgrund Accrding t the Centers fr Disease Cntrl and Preventin (CDC), abut 600,000 peple die f heart disease every year in the United States and it is the leading cause f death fr bth men and wmen.(2) By targeting HDL/LDL/ttal chlesterl, bld sugar, bld pressure, and weight fr example, the risk fr heart disease is lessened. Prgrams have evlved t target this disease and the assciated risk factrs. Intensive cardiac rehabilitatin (ICR) is a multidimensinal prgram incrprating many aspects f wellbeing, which fcus n reducing heart disease risk factrs. The Dr. Dean Ornish Prgram fr Reversing Heart Disease is a 72 hur utpatient ICR prgram (cmpleted in ne hur sessins) and is prpsed as an alternative t surgical treatment in patients with heart disease. The fcus f the Ornish prgram is t target fur cmpnents which are thught t slw, stp, and even reverse the prgressin f crnary artery disease. The fur cmpnents alng with smking cessatin are: lw-fat, whle fd nutritin; stress management; mnitred fitness; and grup supprt. Fr patients enrlled in the prgram, there is a team f medical prfessinals assigned t their treatment (i.e., physician/medical directr, nurse case manager, exercise physilgist, clinical psychlgist, registered stress management instructr, and a registered dietician). The prgram fcuses n lifestyle changes versus the use f medicatins and surgery t treat and prevent crnary artery disease. The clinical utcmes f the prgram are imprvements in bld pressure, weight, bdy mass index, chlesterl, angina, depressin, hstility, and vitality.(3) 2

3 Medical Plicy Dr. Dean Ornish is the funder f the nnprfit Preventive Medicine Research Institute (PMRI) and has been cnducting research fr ver 30 years n hw diet and lifestyle can affect health and verall well-being. The fllwing is a review f the literature which fcuses n the effects f lifestyle changes as treatment/preventin fr heart disease. Literature Review In 2010, the Centers fr Medicare and Medicaid Services (CMS) began cvering services fr patients enrlled in the Ornish prgram under a new categry: Intensive Cardiac Rehabilitatin. The criteria fr eligibility is further described in the sectin titled Medicare Natinal Cverage belw. In a prspective, randmized cntrlled trial (RCT) by Ornish et al. (1990), the investigatrs assigned 28 patients t an experimental grup (lw-fat vegetarian diet, smking cessatin, training in stress management, and mderate exercise) and 20 patients t a usual-care grup in rder t determine whether cmprehensive lifestyle changes affect crnary athersclersis after 1 year.(4) In the analysis f 195 crnary artery lesins by quantitative crnary angigraphy, the average percentage diameter stensis regressed frm 40.0 (standard deviatin [SD]: 16.9%) t 37.8 (SD: 16.5%) in the experimental grup and prgressed frm 42.7 (SD: 15.5%) t 46.1 (SD: 18.5%) in the cntrl grup. In the analysis f nly lesins greater than 50% stensis, the average percentage diameter stensis regressed frm 61.1 (SD: 8.8%) t 55.8 (11.0%) in the experimental grup and prgressed frm 61.7 (SD: 9.5%) t 64.4 (SD: 16.3%) in the cntrl grup. With an average change twards regressin in 82% f the experimental-grup patients, the investigatrs cncluded that cmprehensive lifestyle changes may be able t bring abut regressin f even severe crnary athersclersis after nly 1 year, withut the use f lipid-lwering drugs. Ornish et al. (1998) published a RCT cnducted frm n the feasibility f patients t sustain intensive lifestyle changes fr 5 years and the effects f these changes (withut lipid-lwering medicatins) n crnary heart disease.(5) Patients wh had mderate t severe crnary heart disease were randmized t either the Lifestyle Mdificatin Prgram (10% fat whle fds diet, aerbic exercise, stress management training, and grup psychscial supprt) r t a usual-care cntrl grup. The investigatrs fund that the experimental grup made and maintained cmprehensive lifestyle changes fr 5 years, whereas the cntrl grup had mre mderate changes. The average percent diameter stensis (assessed by quantitative crnary arterigraphy) at baseline decreased 1.75 abslute percentage pints after 1 year (a 4.5% relative imprvement) and by 3.1 abslute percentage pints after 5 years (a 7.9% relative imprvement) in the experimental grup. In the cntrl grup, the average percent diameter stensis increased by 2.3 percentage pints after 1 year (a 5.4% relative wrsening) and by 11.8 percentage pints after 5 years (a 27.7% relative wrsening); P=.001 between grups. The cntrl grup had mre than twice as many cardiac events (risk rati fr any event fr the cntrl grup, 2.47 [95% cnfidence interval (CI): ]). The investigatrs cncluded that in the experimental grup there was mre regressin f crnary athersclersis ccurring after 5 years than after 1 year. In the cntrl grup, crnary athersclersis cntinued t prgress and mre than twice as many cardiac events ccurred. Guld et al. (1992) cnducted a randmized, cntrlled, blinded arterigraphic trial t determine the effects f the Lifestyle Mdificatin Prgram n gemetric dimensins, shape, and fluid dynamic characteristics f crnary artery stensis.(6) All stensis dimensins were analyzed, including prximal, minimal, distal diameter, integrated length, exit angles and exit effects, determining stensis shape and a single integrated measure f stensis severity, stensis flw reserve reflecting functinal severity. Cmplex 3

4 Medical Plicy shape change and a stensis-mlding characteristic f statistically significant prgressing severity ccurred with wrsening f stensis flw reserve in the cntrl grup. In the treated grup, cmplex shape change and stensis mlding characteristic f significant regressing severity was bserved with imprved stensis flw reserve in the treatment grup. The results f the study dcumented the multidimensinal characteristics f regressing crnary artery disease. In a RCT by Guld et al. (1995) the investigatrs sught t quantify changes in size and severity f mycardial perfusin abnrmalities by psitrn emissin tmgraphy (PET) in patients with crnary artery disease after 5 years f risk factr mdificatin.(7) Patients were randmized t the Lifestyle Mdificatin Prgram r t usual care by their physician, cnsisting primarily f antianginal therapy. Results f the study shwed that size and severity f perfusin abnrmalities n dipyridamle PET images decreased (imprved) after risk factr mdificatin in the experimental grup whereas the cntrl grup had an increase (wrsening) f size and severity. The percentage f left ventricle perfusin abnrmalities utside 2.5 SDs f thse f nrmal persns (based n 20 diseasefree individuals) n the dipyridamle PET image f nrmalized cunts wrsened in cntrls (mean +/- SE, % +/- 5.6%) and imprved in the experimental grup (mean +/- SE, -5.1% +/- 4.8%); P =.02. The percentage f left ventricle with activity less than 60% f the maximum activity n the dipyridamle PET image f nrmalized cunts wrsened in cntrls (+13.5% +/- 3.8%) and imprved in the experimental grup (-4.2% +/- 3.8%); P =.002. The mycardial quadrant n the PET image with the lwest average activity expressed as a percentage f maximum activity wrsened in cntrls (-8.8% +/- 2.3%) and imprved in the experimental grup (+4.9% +/- 3.3%); P =.001. The size and severity f perfusin abnrmalities n resting PET images were significantly imprved in the experimental grup in cmparisn t the cntrl grup. The relative magnitude f changes in size and severity f PET perfusin abnrmalities was cmparable t r greater than the magnitude f changes in percent diameter stensis, abslute stensis lumen area, r stensis flw reserve dcumented by quantitative crnary arterigraphy. The authrs cncluded that mdest regressin f crnary artery stenses after risk factr mdificatin is assciated with decreased size and severity f perfusin abnrmalities n rest-dipyridamle PET images. In a RCT by Pischke et al. (2008) the authrs lked at psychlgical well-being during the Lifestyle Heart Trial.(8) Psychlgical distress, anger, hstility, and perceived scial supprt were cmpared by grup (interventin, n=28; cntrl, n=20) and time (baseline, 1 year, and 5 years) and examined the relatinships f lifestyle changes t cardiac variables. Reductins in psychlgical distress and hstility in the experimental grup (when cmpared with cntrls) were bserved after 1 year; p<0.5. By 5 years, imprvements in diet were related t weight reductin and decreases in percent diameter stensis. Imprvements in stress management were related t decreases in percent diameter stensis at bth fllw-ups; all p<0.5. The findings f this study shw the imprtance f targeting multiple health behavirs in secndary preventin f crnary heart disease. Pischke et al. (2007) lked at whether changes in lifestyle are feasible and beneficial in patients with crnary heart disease wh have a left ventricular ejectin fractin (LVEF) <40%.(9) A grup f 50 patients with angigraphically dcumented LVEF 40% (mean: 33.4 ± 7.3; range: 15 40%) was cmpared t 186 patients with LVEF >40% (mean: 58.2 ± 9.6; range: 42 87%). All were participants in the Multicenter Lifestyle Demnstratin Prject (MLDP) and were nn-smkers. Crnary risk factrs, lifestyle and quality f life (SF-36) were assessed at baseline, 3 and 12 mnths. The authrs fund that patients shwed significant imprvements (all p<.05) in lifestyle behavirs, bdy weight, bdy fat, bld pressure, resting heart rate, ttal and LDL-chlesterl, exercise capacity, and 4

5 Medical Plicy quality f life by 3 mnths, regardless f LVEF. Mst imprvements were maintained ver 12 mnths. In a study by Frattarli et al. (2008), the authrs investigated the effects f intensive lifestyle mdificatin n symptm relief.(10) Changes in angina pectris, crnary risk factrs, quality f life, and lifestyle behavirs were investigated in patients with stable crnary artery disease wh were enrlled in the multisite cardiac lifestyle interventin prgram (an nging health insurance cvered lifestyle interventin cnducted at 22 sites in the United States). Nn-smking patients with crnary artery disease were asked t make changes in diet, engage in mderate exercise, and practice stress management (757 men, 395 wmen; mean age 61 years). At baseline, 108 patients (43% wmen) reprted mild angina while 174 patients (37% wmen) reprted limiting angina. After 12 weeks, 74% f the patients were angina free, and an additinal 9% wh reprted limiting angina at baseline, nw reprted mild angina. This imprvement in angina was significant fr patients with mild and limiting angina at baseline regardless f gender; p <0.01. Significant imprvements in cardiac risk factrs, quality f life, and lifestyle behavirs were bserved. Thse patients with angina wh became angina free by 12 weeks shwed the greatest imprvements in exercise capacity, depressin, and health-related quality f life; p <0.05. The authrs cncluded that by making intensive lifestyle changes, patients culd drastically reduce their need fr revascularizatin prcedures. Silberman et al. (2010) investigated the effectiveness f an ICR prgram in imprving health utcmes at multiple sites.(11) The study included 2,974 men and wmen frm 24 sciecnmically diverse sites wh participated in an ICR prgram. Changes in cardivascular disease were assessed at baseline, 12 weeks, and 1 year. Results f the study shwed that 88% f patients remained enrlled in the prgram after 12 weeks and 78.1% remained enrlled in the prgram after 1 year. Statistically significant imprvements were seen after 12 weeks in BMI, triglycerides, LDL, ttal chlesterl, HbA1c, systlic bld pressure, diastlic bld pressure, depressin, hstility, exercise, and functinal capacity. These differences als remained significant after 1 year. The authrs cncluded that the intensive cardiac rehabilitatin prgram was feasible and sustainable fr mst patients and was assciated with the numerus subjective and bjective imprvements in health utcmes. In a study by Daubenmier et al. (2007), the authrs evaluated the additive and interactive effects f 3-mnth changes in health behavirs (dietary fat intake, exercise, and stress management) n 3-mnth changes in crnary risk and psychscial factrs amng 869 nn-smking CHD patients (24% female) enrlled in the Multisite Cardiac Lifestyle Interventin Prgram.(12) Health behavirs, crnary risk factrs, and psychscial factrs were analyzed at baseline and 2-mnths. Multiple regressin analysis evaluated changes in dietary fat intake and hurs per week f exercise and stress management as predictrs f changes in crnary risk and psychscial factrs. Results shwed the fllwing: A significant verall imprvement in crnary risk Reductins in dietary fat intake predicted reductins in weight, ttal chlesterl, lw-density lipprtein chlesterl, and interacted with increased exercise t predict reductin in perceived stress Increase in exercise predicted imprvements in ttal chlesterl and exercise capacity (fr wmen) 5

6 Medical Plicy Increased stress management was related t reductins in weight, ttal chlesterl/ high-density lipprtein chlesterl (fr men), triglycerides, hemglbin A1c (in patients with diabetes), and hstility The authrs cncluded that imprvements in dietary fat intake, exercise, and stress management were individually, additively, and interactively related t crnary risk and psychscial factrs. The results suggest that multicmpnent prgrams fcusing n diet, exercise, and stress management may benefit patients with crnary heart disease. Kertge et al. (2003) published a study examining the medical and psychscial characteristics f 440 patients (mean age 58 years, 21% wmen) with crnary artery disease at baseline and at 3-mnth and 12-mnth fllw-ups.(13) All patients were participants in the Multicenter Lifestyle Demnstratin Prject. Significant imprvements in diet, exercise, stress management practices, medical factrs (e.g., plasma lipids, bld pressure, bdy weight, exercise capacity) and psychscial factrs (e.g., quality f life) were maintained by bth genders ver the curse f the study. The authrs cncluded that these results demnstrate a multi-cmpnent lifestyle change prgram fcusing n diet, exercise, stress management, and scial supprt can be successfully implemented at hspitals in diverse regins f the United States. In 2011, Chainani-Wu et al. cnducted a prspective chrt study f 131 patients (59.2% wmen and 43.1% with diabetes mellitus), 56 with crnary heart disease (37.5% wmen and 27.3% diabetes mellitus), and 75 at high risk with 3 crnary heart disease risk factrs and/r diabetes mellitus (76% wmen and 54.7% diabetes mellitus).(14) The purpse f the study was t evaluate the changes in emerging cardiac bimarkers, cgnitive functin, and scial supprt measures after a cmprehensive lifestyle interventin which included a lw-fat, whle-fds, plant-based diet, exercise, stress management, and grup supprt meetings. Imprvement in all targeted health behavirs was seen in bth high-risk and CHD grups (all p <0.001) at 3 mnths, with reductins in bdy mass index, systlic and diastlic bld pressure, waist/hip rati, C- reactive prtein, insulin, lw-density lipprtein, high-density and ttal chlesterl, aplipprteins A1 and B (all p <0.009) were bserved. The quality f life, cgnitive functining, and scial supprt measures significantly imprved. The authrs cncluded that lifestyle changes can be fllwed by favrable changes in traditinal and emerging crnary heart disease bimarkers, quality f life, scial supprt, and cgnitive functin amng thse with, r at high risk, f crnary heart disease. Summary By fllwing an intensive cardiac rehabilitatin prgram such as the Ornish Prgram fr Reversing Heart Disease; many studies have shwn benefits in patients with heart disease and thse at risk f heart disease. The evidence has shwn imprved quality f life (stress reductin, physical functin, and verall well-being), risk factr imprvements, and fewer cardiac events. Fr patients with any f the cnditins described in the plicy statement abve, intensive cardiac rehabilitatin prgrams (i.e., Dr. Dean Ornish Prgram fr Reversing Heart Disease) may be cnsidered medically necessary. Practice Guidelines and Psitin Statements Accrding t the 2013 American Cllege f Cardilgy/American Heart Assciatin (ACC/AHA) Guideline n the Treatment f Bld Chlesterl t Reduce Athersclertic Cardivascular Risk in Adults: A Reprt f the American Cllege f Cardilgy/American Heart Assciatin Task Frce n Practice Guidelines: Heart-healthy lifestyle habits are the fundatin f [athersclertic cardivascular disease] ASCVD preventin. Based n certain risk factrs (e.g., age, LDL/chlesterl levels) and cmrbidities, the AHA 6

7 Medical Plicy recmmends the additin f medicatins such as statins.(15) In cnclusin, the guidelines state: Thrugh a rigrus prcess, 4 grups f individuals were identified fr whm an extensive bdy f RCT evidence demnstrated a reductin in ASCVD events with a gd margin f safety frm mderate- r highintensity statin therapy: Fur Statin Benefit Grups: 1. Individuals with clinical ASCVD 2. Individuals with primary elevatins f LDL-C 190 mg/dl 3. Individuals 40 t 75 years f age with diabetes and LDL-C 70 t 189 mg/dl withut clinical ASCVD 4. Individuals withut clinical ASCVD r diabetes wh are 40 t 75 years f age and have LDL-C 70 t 189 mg/dl and an estimated 10-year ASCVD risk f 7.5%. This requires a clinician-patient discussin. Individuals in the last grup can be identified by using the Pled Chrt Equatins fr ASCVD risk predictin develped by the Risk Assessment Wrk Grup. Lifestyle cunseling shuld ccur at the initial and fllw-up visits as the fundatin fr statin therapy and may imprve the verall risk factr prfile. The AHA/ACC 2013 guideline n lifestyle management t reduce cardivascular risk recmmends specific dietary and physical activity needs fr lwering LDL and bld pressure.(16) The recmmendatins fr bth LDL and bld pressure are as fllws: Diet Cnsume a dietary pattern that emphasizes intake f vegetables, fruits, and whle grains; includes lw-fat dairy prducts, pultry, fish, legumes, nntrpical vegetable ils, and nuts; and limits intake f sweets, sugarsweetened beverages, and red meats. a. Adapt this dietary pattern t apprpriate calrie requirements, persnal and cultural fd preferences, and nutritin therapy fr ther medical cnditins (including diabetes). b. Achieve this pattern by fllwing plans such as the DASH dietary pattern, the USDA Fd Pattern, r the AHA Diet. Physical Activity Lipids Bld Pressure 1. In general, advise adults t engage in aerbic physical activity t reduce LDL-C and nn HDL-C: 3 4 sessins per wk, lasting n average 40 min per sessin, and invlving mderate- t vigrus-intensity physical activity. 1. In general, advise adults t engage in aerbic physical activity t lwer BP: 3 4 sessins per wk, lasting n average 40 min per sessin, and invlving mderate- t vigrus-intensity physical activity. 7

8 Medical Plicy Medicare Natinal Cverage There is a Natinal Cverage Determinatin (NCD) fr Ornish Prgram fr Reversing Heart Disease ( ).(17,1) Cardiac Rehabilitatin/ICR Prgram Beneficiary Cverage Effective January 1, 2010, Medicare Part B cvers Cardiac Rehabilitatin and ICR prgram services fr beneficiaries wh have experienced ne r mre f the fllwing: An acute mycardial infarctin within the preceding 12 mnths; A crnary artery bypass surgery; Current stable angina pectris; Heart valve repair r replacement; Percutaneus transluminal crnary angiplasty r crnary stenting; A heart r heart-lung transplant; r Other cardiac cnditins as specified thrugh a natinal cverage determinatin (NCD) (Cardiac Rehabilitatin nly). Cardiac Rehabilitatin /ICR Prgram Cmpnent Requirements Cvered Cardiac Rehabilitatin and ICR prgrams must include the fllwing cmpnents: Physician-prescribed exercise - This physical activity includes aerbic exercise cmbined with ther types f exercise (i.e., strengthening, stretching) as determined t be apprpriate fr individual patients by a physician each day Cardiac Rehabilitatin /ICR items/services are furnished. Cardiac risk factr mdificatin - This includes educatin, cunseling, and behaviral interventin, tailred t the patients individual needs. Psychscial assessment - This assessment means an evaluatin f an individual s mental and emtinal functining as it relates t the individual s rehabilitatin. It shuld include an assessment f thse aspects f the individual s family and hme situatin that affects the individual s rehabilitatin treatment and a psychscial evaluatin f the individual s respnse t (and rate f prgress under) the treatment plan. Outcmes assessment - These shuld include: (1) minimally, assessments frm the cmmencement and cnclusin f Cardiac Rehabilitatin /ICR, based n patient-centered utcmes which must be measured by the physician immediately at the beginning and end f the prgram, and (2) bjective clinical measures f the effectiveness f 8

9 Medical Plicy References the Cardiac Rehabilitatin /ICR prgram fr the individual patient, including exercise perfrmance and self-reprted measures f exertin and behavir. An individualized treatment plan - This plan shuld be written and tailred t each individual patient and include (1) a descriptin f the individual s diagnsis,(2) the type, amunt, frequency, and duratin f the Cardiac Rehabilitatin /ICR items/services furnished, and (3) the gals set fr the individual under the plan. The individualized treatment plan must be established, reviewed, and signed by a physician every 30 days. Cardiac Rehabilitatin Sessins Frequency Limitatins Cardiac Rehabilitatin sessins are limited t a maximum f 2 nehur sessins per day (up t 36 sessins, ver a perid f up t 36 weeks), with the ptin fr an additinal 36 sessins ver an extended perid f time if apprved by the Medicare cntractr under Sectin 1862(a)(1)(A) f the Scial Security Act. ICR sessins are limited t 72 ne-hur sessins, up t 6 sessins per day, ver a perid f up t 18 weeks. 1. Centers fr Medicare and Medicaid Services (CMS). Prvider Inquiry Assistance: Cardiac Rehabilitatin and Intensive Cardiac Rehabilitatin JA Retrieved n Octber 15, 2014 frm Cntracting/CntractrLearningResurces/dwnlads/JA6850.pdf. 2. Centers fr Disease Cntrl and Preventin (CDC). Heart Disease Facts. Updated Retrieved n Octber 15, 2014 frm 3. Preventive Medicine Research Institute. Ornish Spectrum Reversing Heart Disease Prgram. Retrieved n Octber 20, 2014 frm 4. Ornish D, Brwn SE, Scherwitz LW et al. Can Lifestyle Changes Reverse Crnary Heart Disease: The Lifestyle Heart Trial. Lancet. 1990; 336: Ornish D, Scherwitz LW, Billings JH et al. Intensive Lifestyle Changes fr Reversal f Crnary Heart Disease. JAMA. 1998; 280(23): Guld KL, Ornish D, Kirkeeide R et al. Imprved Stensis Gemetry by Quantitative Crnary Arterigraphy After Vigrus Risk Factr Mdificatin. American Jurnal f Cardilgy. 1992; 69: Guld KL, Ornish D, Scherwitz L et al. Changes in Mycardial Perfusin Abnrmalities by Psitrn Emissin Tmgraphy After Lng-Term, Intense Risk Factr Mdificatin. JAMA. 1995; 20:274(11): Pischke C, Scherwitz L, Weinder G et al. Lng-Term Effects f Lifestyle Changes n Well-Being and Cardiac Variables Amng Crnary Heart Disease Patients. Health Psychlgy. 2008; 27: Pischke C, Weidner G, Ellitt-Eller M et al. Lifestyle Changes and Clinical Prfile in Crnary Heart Disease Patients with an Ejectin Fractin f 40% r >40% in the Multicenter Lifestyle Demnstratin. Eurpean Jurnal f Heart Failure. 2007; 9(9):

10 Medical Plicy 10. Frattarli J, Weidner G, Merritt-Wrden T et al. Angina Pectris and Athersclertic Risk Factrs in the Multisite Cardiac Lifestyle Interventin Prgram. American Jurnal f Cardilgy. 2008; 101: Silberman A, Banthia R, Estay I et al. The Effectiveness and Efficacy f an Intensive Cardiac Rehabilitatin Prgram in 24 Sites. American Jurnal f Health Prmtin. 2010; 4: Daubenmier J, Weidner G, Sumner M et al. The Cntributin f Changes in Diet, Exercise, and Stress Management t Changes in Crnary Risk in Wmen and Men in the Multisite Cardiac Lifestyle Interventin Prgram. Annals f Behaviral Medicine. 2007; 33(1): Kertge J, Weidner G, Ellitt-Eller M et al. Imprvement in Medical Risk Factrs and Quality f Life in Wmen and Men With Crnary Artery Disease in the Multicenter Lifestyle Demnstratin Prject. American Jurnal f Cardilgy. 2003; 91: Chainani-Wu N, Weidner G, Purnell DM et al. Changes in emerging cardiac bimarkers after an intensive lifestyle interventin. American Jurnal f Cardilgy. 2011; 108(4): Stne NJ, Rbinsn JG, Lichtenstein AH et al ACC/AHA Guideline n the Treatment f Bld Chlesterl t Reduce Athersclertic Cardivascular Risk in Adults: A Reprt f the American Cllege f Cardilgy/American Heart Assciatin Task Frce n Practice Guidelines. Circulatin. 2014; 129:S1-S Eckel RH, Jakicic JM, Ard JD et al AHA/ACC Guideline n Lifestyle Management t Reduce Cardivascular Risk: A Reprt f the American Cllege f Cardilgy/American Heart Assciatin Task Frce n Practice Guidelines. Circulatin. 2014; 129:S76-S Centers fr Medicare and Medicaid Services (CMS). Natinal Cverage Determinatin (NCD) fr Ornish Prgram fr Reversing Heart Disease ( ). Updated Retrieved n Octber 15, 2014 frm Dcumentatin Required fr Clinical Review Histry and physical and/r cnsultatin ntes including: Dcumented cardiac histry Smking histry and cessatin date Prir cardiac prcedure reprt(s) Cding This Plicy relates nly t the services r supplies described herein. Benefits may vary accrding t benefit design; therefre, cntract language shuld be reviewed befre applying the terms f the Plicy. Inclusin r exclusin f a prcedure, diagnsis r device cde(s) des nt cnstitute r imply member cverage r prvider reimbursement. 10

11 Medical Plicy MN/NMN The fllwing services may be cnsidered medically necessary when plicy criteria are met. Services are cnsidered nt medically necessary when plicy criteria are nt met. Type Cde Descriptin CPT Nne G0422 Intensive cardiac rehabilitatin; with r withut cntinuus ECG mnitring with exercise, per sessin HCPC G0423 Intensive cardiac rehabilitatin; with r withut cntinuus ECG mnitring; withut exercise, per sessin ICD-9 Prcedure Nne ICD-10 Prcedure Fr dates f service n r after 10/01/2015 Nne ICD-9 Diagnsis All Diagnses ICD-10 Diagnsis Fr dates f service n r after 10/01/2015 All Diagnses Plicy Histry This sectin prvides a chrnlgical histry f the activities, updates and changes that have ccurred with this Medical Plicy. Effective Date Actin Reasn 11/26/2014 Custm plicy Medical Plicy Cmmittee Definitins f Decisin Determinatins Medically Necessary: A treatment, prcedure r drug is medically necessary nly when it has been established as safe and effective fr the particular symptms r diagnsis, is nt investigatinal r experimental, is nt being prvided primarily fr the cnvenience f the patient r the prvider, and is prvided at the mst apprpriate level t treat the cnditin. Investigatinal/Experimental: A treatment, prcedure r drug is investigatinal when it has nt been recgnized as safe and effective fr use in treating the particular cnditin in accrdance with generally accepted prfessinal medical standards. This includes services where apprval by the federal r state gvernmental is required prir t use, but has nt yet been granted. Split Evaluatin: Blue Shield f Califrnia / Blue Shield f Califrnia Life & Health Insurance Cmpany (Blue Shield) plicy review can result in a Split Evaluatin, where a treatment, prcedure r drug will be cnsidered t be investigatinal fr certain indicatins r cnditins, but will be deemed safe and effective fr ther indicatins r cnditins, and therefre ptentially medically necessary in thse instances. 11

12 Medical Plicy Prir Authrizatin Requirements This service (r prcedure) is cnsidered medically necessary in certain instances and investigatinal in thers (refer t plicy fr details). Fr instances when the indicatin is medically necessary, clinical evidence is required t determine medical necessity. Fr instances when the indicatin is investigatinal, yu may submit additinal infrmatin t the Prir Authrizatin Department. Within five days befre the actual date f service, the Prvider MUST cnfirm with Blue Shield that the member's health plan cverage is still in effect. Blue Shield reserves the right t revke an authrizatin prir t services being rendered based n cancellatin f the member's eligibility. Final determinatin f benefits will be made after review f the claim fr limitatins r exclusins. Questins regarding the applicability f this plicy shuld als be directed t the Prir Authrizatin Department. Please call r visit the Prvider Prtal The materials prvided t yu are guidelines used by this plan t authrize, mdify, r deny care fr persns with similar illness r cnditins. Specific care and treatment may vary depending n individual need and the benefits cvered under yur cntract. These Plicies are subject t change as new infrmatin becmes available. 12

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

Cardiac Rehabilitation in the Outpatient Setting Section 8.0 Therapy Subsection 8.03 Rehabilitation

Cardiac Rehabilitation in the Outpatient Setting Section 8.0 Therapy Subsection 8.03 Rehabilitation 8.03.08 Cardiac Rehabilitatin in the Outpatient Setting Sectin 8.0 Therapy Subsectin 8.03 Rehabilitatin Effective Date February 15, 2015 Original Plicy Date September 13, 1989 Next Review Date December

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

Understanding Your Total-Cholesterol-to-HDL Ratio

Understanding Your Total-Cholesterol-to-HDL Ratio Understanding Yur Ttal-Chlesterl-t-HDL Rati Yur ttal-chlesterl-t-hdl rati is measured during a bld test called a lipid prfile. This wrksheet will help yu learn mre abut this rati. It will als help yu:

More information

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009 CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid

Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid Medical Plicy 1.01.20 Cntinuus r Intermittent Mnitring f Glucse in Interstitial Fluid Sectin 1.0 Durable Medical Equipment Subsectin Effective Date February 27, 2015 Original Plicy Date February 23, 2000

More information

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management

More information

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO NIA Magellan 1 Spine Care Prgram Interventinal Pain Management Frequently Asked Questins (FAQs) Fr Medicare Advantage HMO and PPO Questin GENERAL Why is Flrida Blue implementing a Spine Management prgram

More information

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS INTRODUCTION This ntice prvides an verview f the parental special educatin rights, smetimes called prcedural safeguards

More information

2018 Medical Association Poster Symposium Guidelines

2018 Medical Association Poster Symposium Guidelines 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS) Questin GENERAL Why did MHS implement a Medical Specialty Slutins Prgram? Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Managed Health Services (MHS) Answer Effective Nvember

More information

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018 Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential

More information

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training Iwa Early Peridic Screening, Diagnsis and Treatment Care fr Kids Prgram Prvider Training The Early Peridic Screening, Diagnsis and Treatment (EPSDT) Care fr Kids prgram is Iwa s Medicaid prgram fr children.

More information

A. Catalonia World Health Organization Demonstration Project

A. Catalonia World Health Organization Demonstration Project A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin

More information

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health

More information

Clinical Practice Guideline for the Management of Obesity in Adults

Clinical Practice Guideline for the Management of Obesity in Adults Clinical Practice Guideline fr the Management f Obesity in Adults BACKGROUND The prevalence f besity is reaching epidemic prprtins. Obesity is a risk factr fr Type 2 diabetes mellitus, hypertensin, dyslipidemia,

More information

Solid Organ Transplant Benefits to Change for Texas Medicaid

Solid Organ Transplant Benefits to Change for Texas Medicaid Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface HTN-2 (NQF 0018): Cntrlling High Bld Pressure Measure Steward: NCQA CMS Web Interface V2.0 Page 1 f 18 11/13/2017 Cntents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION... 4

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will: Nutritin Care Prcess Mdel Tutrials Nutritin Care Prcess and Terminlgy Cmmittee Academy f Nutritin and Dietetics Nutritin Care Prcess Terminlgy 2015 Editin Nutritin Mnitring & Evaluatin: Overview & Definitin

More information

Diabetes: HbA1c Poor Control (NQF 0059)

Diabetes: HbA1c Poor Control (NQF 0059) Diabetes: HbA1c Pr Cntrl (NQF 0059) EMeasure Name Diabetes: HbA1c Pr Cntrl EMeasure Id Pending Versin Number 1 Set Id Pending Available Date N infrmatin Measurement January 1, 20xx thrugh Perid December

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Luisiana Healthcare Cnnectins Prviders Questin GENERAL Why did Luisiana Healthcare Cnnectins implement a Medical Prgram? Answer

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070) Crnary Artery Disease (CAD): Beta Blcker Therapy fr CAD Patients with Prir Mycardial Infarctin (MI) (NQF 0070) EMeasure Name Crnary Artery Disease EMeasure Id Pending (CAD): Beta Blcker Therapy fr CAD

More information

PET FORM Planning and Evaluation Tracking ( Assessment Period)

PET FORM Planning and Evaluation Tracking ( Assessment Period) Divisin f: Behaviral Studies PET FORM Planning and Evaluatin Tracking (2010 2011 Assessment Perid) Persn Respnsible fr this Divisin: Jerry Mller Department f: Behaviral Sciences Persn Respnsible fr this

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment

More information

High Performance Network Quality Criteria for Designation

High Performance Network Quality Criteria for Designation Selected quality measures include: Specialty Measure Descriptin Allergy / Immunlgy Asthma Drug Mgt Vaccine Pneumnia Vaccine High Perfrmance Netwrk Quality Criteria fr Designatin AvMed has selected certain

More information

Specifically, on page 12 of the current evicore draft, we find the statement:

Specifically, on page 12 of the current evicore draft, we find the statement: Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit

More information

Frontier School of Innovation District Wellness Policy

Frontier School of Innovation District Wellness Policy Frntier Schl f Innvatin 6700 Crprate dr. Suite 150 Phne: 816-363-1907 http://www.kcfsi.rg/ Frntier Schl f Innvatin District Wellness Plicy The Bard prmtes healthy schls, by supprting wellness, gd nutritin,

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

LAST UPDATED FEBRUARY 1, Prepared exclusively for UCanQuit2 Chat Team

LAST UPDATED FEBRUARY 1, Prepared exclusively for UCanQuit2 Chat Team LAST UPDATED FEBRUARY 1, 2018 Prepared exclusively fr UCanQuit2 Chat Team HOW TO USE THIS GUIDE The UCanQuit2 Live Chat Resurces Guide was created fr the UCanQuit2 Live Chat Team. This guide includes a

More information

2018 CMS Web Interface

2018 CMS Web Interface PREV-13: Statin Therapy fr the Preventin and Treatment f Cardivascular Disease CMS Web Interface PREV-13: Statin Therapy fr the Preventin and Treatment f Cardivascular Disease Measure Steward: CMS CMS

More information

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre

More information

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit

More information

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...

More information

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states. Nvel methds and appraches fr sensing, evaluating, mdulating and regulating md and emtinal states. 2018 Jy Academic Grant Call fr Prpsals Intrductin The Annual Jy grant initiative aims t prmte and cntribute

More information

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher: Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface PREV-13: Statin Therapy fr the Preventin and Treatment f Cardivascular Disease Measure Steward: CMS CMS Web Interface V2.1 Page 1 f 27 06/25/ Cntents INTRODUCTION... 4 CMS WEB INTERFACE

More information

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...

More information

Folotyn (pralatrexate)

Folotyn (pralatrexate) Fltyn (pralatrexate) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Original Effective Date: 10/01/2015 Current Effective Date: 01/01/2018TBD03/01/2017 POLICY A. INDICATIONS The indicatins

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-13: Statin Therapy fr the Preventin and Treatment f Cardivascular Disease Measure Steward: CMS Web Interface V1.1 Page 1 f 27 12/15/2016 Cntents INTRODUCTION... 4 WEB INTERFACE SAMPLING

More information

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH Aurra Health Care s Research Subject Prtectin Prgram (RSPP) This guidance dcument will utline the prper prcedures fr btaining and dcumenting

More information

Evaluation of a Shared Decision Making Intervention between Patients and Providers to Improve Menopause Health Outcomes: Issue Brief

Evaluation of a Shared Decision Making Intervention between Patients and Providers to Improve Menopause Health Outcomes: Issue Brief Evaluatin f a Shared Decisin Making Interventin between Patients and Prviders t Imprve Menpause Health Outcmes: Issue Brief Key Findings Tablet technlgy can be successfully incrprated int primary practices

More information

Reliability and Validity Plan 2017

Reliability and Validity Plan 2017 Reliability and Validity Plan 2017 Frm CAEP The principles fr measures used in the CAEP accreditatin prcess include: (a) validity and reliability, (b) relevance, (c) verifiability, (d) representativeness,

More information

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent

More information

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10 Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family

More information

Module 6: Goal Setting

Module 6: Goal Setting Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals

More information

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS 1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics

More information

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA)

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA) Plicy Medical Plicy Manual Apprved: D Nt Implement Until 1/1/18 Applied Behaviral Analysis (ABA) This medical plicy will apply t self-funded grups upn their renewal, beginning 1/1/18. Des nt apply t BlueCare.

More information

Appendix C. Master of Public Health. Practicum Guidelines

Appendix C. Master of Public Health. Practicum Guidelines Appendix C Master f Public Health Practicum Guidelines 0 Gergia State University, Schl f Public Health Master f Public Health Practicum Guidelines Fr mre infrmatin, cntact Jessica Hwell Pratt, MPH Practicum

More information

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient Image Surce: https://s-media-cache-ak0.pinimg.cm/736x/7c/29/91/7c2991805f004e1ca05e42a79883f4a7.jpg 6/30/2017 Curse Objectives A Practical Guide t Cding fr Audilgists in 2017 Megan Keirans, AuD University

More information

Ontario 2018 provincial election issues backgrounder

Ontario 2018 provincial election issues backgrounder Ontari 2018 prvincial electin issues backgrunder Dietitians f Canada Pririties May 2018 Access t dietitians in Ontari s health system Diet is the #1 risk factr fr chrnic diseases that cst Ontari $90 billin

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-6 (NQF 0034): Clrectal Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

ARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST

ARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST ARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST 7 th July 2017 Cntent 1 Intrductin 2 Tpics fr EOI in the 4 th call 3 The applicatin prcess and imprtant dates 4 Guideline fr EOIs Deadline

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

Assessment criteria for Primary Health Disciplines Eligibility for Recognition as Credentialled Diabetes Educator. December 2015 ADEA

Assessment criteria for Primary Health Disciplines Eligibility for Recognition as Credentialled Diabetes Educator. December 2015 ADEA Assessment criteria fr Primary Health Disciplines Eligibility fr Recgnitin as Credentialled Diabetes Educatr December 2015 ADEA ASSESSMENT CRITERIA FOR PRIMARY HEALTH DICIPLINES ELIGIBILITY FOR RECOGNITION

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Session78-P.doc College Adjustment And Sense Of Belonging Of First-Year Students: A Comparison Of Learning Community And Traditional Students

Session78-P.doc College Adjustment And Sense Of Belonging Of First-Year Students: A Comparison Of Learning Community And Traditional Students Sessin78-P.dc Cllege Adjustment And Sense Of Belnging Of First-Year Students: A Cmparisn Of Learning Cmmunity And Traditinal Students Jennifer Ann Mrrw, Ph.D. Assistant Prfessr Old Dminin University Department

More information

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): Angitensin

More information

Corporate Governance Code for Funds: What Will it Mean?

Corporate Governance Code for Funds: What Will it Mean? Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,

More information

Code of Conduct for Employees

Code of Conduct for Employees Crprate Human Resurces Plicy Cntent Updated: 2016-06-22 Wrk Envirnment Plicy N: HR-01-09 Page 1 f 5 Apprval: 2014-09-24 Cde f Cnduct fr Emplyees POLICY STATEMENT The residents and businesses f the City

More information

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening

More information

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics Independent Charitable Patient Assistance Prgram (IPAP) Cde f Ethics Independent charitable patient assistance prgrams (IPAPs) fcus n the needs f patients wh are insured, meet certain financial limitatin

More information

Programme of Learning. Physical Education. Key Stage 4 Year 10 BTEC Sport

Programme of Learning. Physical Education. Key Stage 4 Year 10 BTEC Sport Prgramme f Learning Physical Educatin Key Stage 4 Year 10 BTEC Sprt BTEC Sprt Level 2 Unit 1Fitness fr Sprt and Exercise... 2 Learning aim A: Knw abut the cmpnents f fitness and the principles f training...

More information

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit. Cmprehensive Diagnstic Evaluatin (CDE) Guidelines t Access the Applied Behavir Analysis (ABA) Benefit May 5, 2017 Clinical infrmatin that utlines medical necessity is required t supprt the need fr initial

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745 Generic Brand HICL GCN Exceptin/Other NALTREXONE CONTRAVE ER 41389 /BUPROPION LORCASERIN BELVIQ 34733 PHENTERMINE PHENTERMINE 20691 20692 20693 20713 PHENTERMINE LOMAIRA 20715 PHENTERMINE/TO PIRAMATE GUIDELINES

More information

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): EMeasure

More information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in

More information

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals. 27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface MH-1 (NQF 0710): Depressin Remissin at Twelve Mnths Measure Steward: MNCM CMS Web Interface V2.0 Page 1 f 27 11/13/2017 Cntents INTRODUCTION... 4 CMS WEB INTERFACE SAMPLING INFORMATION...

More information

The principles of evidence-based medicine

The principles of evidence-based medicine The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface MH-1 (NQF 0710): Depressin Remissin at Twelve Mnths Measure Steward: MNCM CMS Web Interface V2.1 Page 1 f 27 06/25/ Cntents INTRODUCTION... 4 CMS WEB INTERFACE SAMPLING INFORMATION...

More information

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL Cncussin awareness has increased significantly in recent years. The Natinal Cllegiate Athletic Assciatin (NCAA), Natinal Athletic Trainers Assciatin

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

Improving Surveillance and Monitoring of Self-harm in Irish Prisons HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June

More information

CDC Influenza Technical Key Points February 15, 2018

CDC Influenza Technical Key Points February 15, 2018 CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity

More information

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program? 3903 Fair Ridge Drive, Suite 209, Fairfax, VA 22033 44121 Harry Byrd Hwy, Suite 285, Ashburn, VA 220147 *Hw did yu hear abut ur prgram? Patient Histry Patient Name: First Middle: Last: Address: City: State:

More information

HSC 106 Personal Health Plan for Learning Activities & Assessment linked to Michigan Teacher Preparation Standards

HSC 106 Personal Health Plan for Learning Activities & Assessment linked to Michigan Teacher Preparation Standards HSC 106 Persnal Health Plan fr Learning Activities & Assessment linked t Michigan Teacher Preparatin Standards Standard 1 Cmpetency 1.1 Understand basic health cntent as it relates t schl health educatin.

More information

Weight Assessment and Counseling for Children and Adolescents (NQF 0024)

Weight Assessment and Counseling for Children and Adolescents (NQF 0024) Weight Assessment and Cunseling fr Children and Adlescents (NQF 0024) EMeasure Name Weight Assessment and EMeasure Id Pending Cunseling fr Children and Adlescents Versin Number 1 Set Id Pending Available

More information